Skip to main content
Equibles

Raj Asarpota

CFO

Maravai Lifesciences Holdings, Inc. (MRVI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Maravai Lifesciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.

Get MRVI alerts

About Raj Asarpota

Raj Asarpota is recorded as CFO at Maravai Lifesciences Holdings, Inc. (MRVI). The newest filing on record that lists Raj Asarpota as CFO at Maravai Lifesciences Holdings, Inc. (MRVI) is dated April 24, 2026. The proxy statement of Maravai Lifesciences Holdings, Inc. reports total compensation of $3,506,793 for Raj Asarpota in fiscal 2025, including a base salary of $253,366. Raj Asarpota has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Maravai Lifesciences Holdings, Inc. on August 6, 2026. Maravai Lifesciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Maravai Lifesciences Holdings, Inc. includes Bernd Brust (CEO and Board Member), William "Trey" Martin, III (CEO and Board Member), William E. Martin III (CEO) and 7 others.

Raj Asarpota on recent calls

“Our second quarter reflects solid execution across both segments with improving margin flow-through. I'll focus on the key drivers behind the quarter, including revenue composition, profitability, and our updated outlook.”
CFO, Q2 2026 Maravai LifeSciences Earnings Conference Call ·
“So, yeah, kind of dusting back and looking at kind of what we've done over the last, now give or take, 12 months.”
CFO, Jefferies Global Healthcare Conference in New York ·
“Building on Bernd's comments, the first quarter reflects solid execution across both segments with improving base demand and strong margin flow-through. I'll focus on the key drivers behind the quarter including revenue composition, profitability and our updated outlook.”
CFO, Maravai Lifesciences Holdings, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Maravai Lifesciences Holdings, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Maravai Lifesciences Holdings, Inc. (MRVI) $253,366 $3,506,793

Recent activity